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Introduction
One of the specific neuropathological hallmarks of Alzheimer's disease (AD) is the extensive extracellular aggregation and deposition of i-amyloid peptides (iAP), forming neuritic plaques and cerebrovascular deposits [41] . Senile plaque-forming iAP consist of 42 amino acid residues in mature form [13] . These are minor fragments of the large, transmembrane i-amyloid precursor protein (APP), located within the extracellular and membrane-spanning domains [17] of this receptor-like cell surface molecule [21] . In an aberrant proteolytic cleavage process [8] APP liberates various potentially amyloidogenic iAP fragments differing in distribution and in physiological and chemical properties [2, 12, 25, 38] . While iAP are also produced during the normal cell metabolism [16] , their physiological effects are very controversial. While i-amyloid fragments exert neurotrophic properties under certain conditions in vitro [47, 48] , ample evidence has recently accumulated on the direct neurotoxicity of, iAP [1, 6, 7, 18, 19, 24, 25, 43] occurring in a dose-dependent manner [48] . It has also been demonstrated that iAP enhance glutamate neurotoxicity and thus render neurons vulnerable to excitotoxic [31] or metabolic insults [22] . Moreover, selective cholinotoxic effects of the i-amyloid (1 -42) peptide (iAP (1 -42) ) were demonstrated both in vitro [40] and in vivo [18] . Relative preservation of neurons containing Ca 2 + -binding proteins after application of multiple iAP were observed. Changes of intracellular free Ca 2 + levels ([Ca 2 + ] i ) after iAP exposure [29] [30] [31] were also reported and indicates that a severe derangement of the intracellular Ca 2 + homeostasis is pivotal in i-amyloid mediated neurotoxicity.
The search for amino acid sequences, critical for the neurotoxic mechanism of iAP, revealed the that 'active core' of the protein is localized within the [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] (iAP (25 -35) ) [12, 38, 40, 48] and possibly within the 31-35 sequence [38] of the peptide. Adjacent amino acid regions such as 1-24 and 36 -42, respectively, may either lend conformational stability to the protein [12] or influence its solubility [2] and perhaps direct exoprotease cleavage. Giovannelli et al. [12] have recently reported that both histolopathologic symptoms and behavioral dysfunctioning decreased 2 weeks after iAP (25 -35) injections, in the nucleus basalis magnocellularis (nbm) of rats, while iAP (1 -40) permanently altered higher brain functions and affected cholinergic neurotransmission.
The nbm plays a critical role in cognitive and memory functions [3] , as shown in several behavioral tasks [35, 45, 46] , by the persistent regulation of higher cortical processes [3] . Moreover, cholinergic neurons of the basal forebrain complex are particularly susceptible to excitotoxic injury and undergo rapid neurodegeneration both in rats [6, 18, 19, 26] and humans [3] . Earlier papers have shown that the cortical cholinergic hypofunction, which is characteristic of AD, is primarily due to degeneration of the nbm [3] that maintains extensive cholinergic projections to cortical structures, such as the parietal cortex [6,26 -28] .
The aim of this paper was to determine behavioral and histochemical alterations after bilateral nbm lesions elicited by iAP in rats throughout a 5-week survival period (Fig. 1) . The peptide containing the iAP (25 -35) sequence coupled with a phenylalaninesulphonate (Phe(SO 3 H)) residue at position 24 (iAP(Phe(SO 3 H) 24 ) [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] was used to determine whether iAP conformation, the rate of the peptide metabolism or water-solubility might play a principal role in i-amyloid mediated neurotoxicity. The additional Phe(SO 3 H) group serves as a protective cap on the molecule, presumably reducing exoprotease cleavage but without influencing its neurotoxic potential (Penke et al., unpublished data) . Similar modifications of other neuropeptides, such as pentagastrin or cholecystokinin octapeptide, were extensively used to study long-lasting effects of these proteins [23] .
Materials and methods

Peptide synthesis
iAP(Phe(SO 3 H) 24 )25-35 was synthesized [18, 19] with slight modifications. Peptide synthesis was ini- 24 )25 -35 was bilaterally injected in the nucleus basalis magnocellularis (nbm). Behavioral changes induced by the peptide were determined by applying specific tests for the assessment of altered motor activities and/or arousal and retention/acquisition functions throughout a 5-week survival period. Subsequently, AChE histochemistry was used to visualize cholinergic fibre loss in parietal cortical sections. tiated with an amide at the C-terminal by a solid-phase technique involving Boc chemistry. Peptide chains were elongated on MBHA resin (0.73 mmol/g) and the syntheses were carried out manually. Couplings were performed with dicydohexylcarbodiimide with the exception of Phe(SO 3 H), which was incorporated in HOBt-ester form. The Boc group was removed by treatment with 50% trifluoroacetic acid in CH 2 Cl 2 . After completion of the synthesis, the peptide was cleaved from the resin with liquid HF. Free peptides were dissolved in distilled water, filtered and lyophilized. The crude peptide was purified by reversephase high performance liquid chromatography (RP-HPLC) on a Vydac-300 C 18 column. The purity was checked by RP-HPLC on a W-Porex 5 C 18 column. Amino acid analysis demonstrated the expected amino acid composition (SO 3 H-FGSNKGAIIGLM) and electrospray mass spectrometry (ES-MS) gave the expected molecular ion. Comparative in vitro studies on mixed glial/neuronal cultures prepared from basal forebrains of rat foetuses using both the native iAP (25 -35) and the modified iAP(Phe(SO 3 H) 24 )25-35 peptides did not reveal significant differences in their neurotoxic potentials (data not shown).
Surgical procedure
Forty eight male Sprague -Dawley rats (280 -310 g) were used in the experiments. The rats were caged individually at least 3 days prior to surgery and kept on a normal diet and tap water ad libitum, in an air-conditioned room (21 92°C) with a 12 h daylight cycle (lights on at 08.00 h). They were anesthetized intraperitoneally with chloral hydrate (375 mg/kg body weight; Merck, Darmstadt, Germany), and their heads were fixed in a stereotaxic apparatus. Twenty animals received 0.4 nmol/2 vl of iAP(Phe(SO 3 H) 24 )25 -35, which was injected slowly ( 0.1 vl/min) into the nbm at both sides of the brain (AP-2.0 mm, lat.93.5 mm, vent. 5.6 mm) [37] with a 10 vl Hamilton microsyringe. The iAP(Phe(SO 3 H) 24 
Home cage acti6ity
The home cage activity apparatus was designed especially for studying animal mobility [44] . It consists of a 207 cm long, 170 cm high and 50 cm wide steel rack divided into 24 totally screened compartments. The home cages of the iAP(Phe(SO 3 H) 24 )25-35-injected and sham-operated animals were placed randomly into the compartments of the home cage activity apparatus. On top of each compartment a passive IR sensor was mounted powered by a 10 V DC power supply. The sensor was fitted with a fresnel lens splitting the IR beam into 16 zones which radiated across the floor of the cage. The 24 sensors were connected to separate switch inputs on an Interpak 2 Interface (Farnell, Leeds, UK) which was linked to an IBM computer equipped with a corresponding 'Home Cage Activity Monitor' software package (version 2.2, ©A. O'Halloran (1993), University College Galway, Ireland). When monitoring begun a sensor dosed if the animal moved from one IR zone into another and the total ambulation score for the compartment was incremented by one. This method using IR sensors avoids removal of the animals from their home cage during the testing period and permits continuous measurements of motor activity.
In addition, the total of ambulation scores during either the light or the dark periods (12/12 h) was used as the measure of the circadian rhythm of the animals.
Locomotor acti6ity
Locomotor activity was recorded 1, 4, 7, 10 and 14 days post-surgery for the iAP(Phe(SO 3 H) 24 )25-35treated, sham-operated and naive control animals according to Caldwell et al. [4] . Activity was monitored using an automatic system, which consisted of four circular perspex arenas, 525 mm in diameter and 350 mm high. Each had a central perspex cylinder of 125 mm in diameter and 350 mm high, providing an annular arena for exploration. Three IR photoswitches consisting of separate beam transmitters and receivers (Farnell, Leeds, UK) were mounted symmetrically (60°a part) outside the arena. An IR beam was transmitted to an IR receiver throughout the arena and the central cylinder, at a height of 1.0-1.5 cm above the floor of the arena. The three IR receivers in each box were connected to separate switch inputs on the individual Interpak 2 Interface (Farnell, Leeds, UK). The interpaks were connected in pairs to a computer (OPUS PC V) via an IBM-intercard (Farnell, Leeds, UK). The software package 'Activity Monitor' (version 12.1, ©A. O'Halloran (1988)) [4] scanned each box for a beam interruption, which was registered as a change in the port status. If there had been a successive beam broken the total count for the box was incremented by one. The software allows for both clockwise and anticlockwise locomotion. Each animal was monitored for a 15 min period.
2.5.
Step-through passi6e shock a6oidance
For the passive shock-avoidance conditioned response test a two-compartment (one-way) step-through apparatus was used [45] . In the training trial the rats were placed in an illuminated chamber lit by a 40 W bulb and allowed to explore the boxes. The latency to step into the dark compartment was recorded (preshock latency). On the second day of the test the rats were placed again on the lit platform. Upon entry into the dark compartment a mild foot-shock (1 mA, for 3 s) was delivered through the grid floor and the rats were returned to their cages. Retesting was performed 24 h later and the latency to step into the dark clamber was recorded (post-shock latency) within a total of a 3 min retesting period.
'Morris' water maze
The 'Morris' water maze is widely used to assess spatial navigation scores in rodents [34] . The rats were placed in a circular pool of water (100 cm in diameter, 80 cm high, water temperature 2691°C) from which they could escape onto a hidden platform (11 cm in diameter and submerged 1.5 cm below the water surface). Both the pool and the platform were constructed of black polyvinyl plastic and therefore offered no clues to guide escape behavior. On the first day of the test rats were placed in the water and allowed to swim with no opportunity for escape for 60 s (pre-training acquisition). On the second and third day of the test, rats were placed in the apparatus facing the perimeter of the pool at one of three different locations used (45°apart) and allowed to escape on the fixed platform (fixed platform test). On days 4 and 5 of the test the platform was moved to the opposite of its original location. The rats were placed in a starting position also on the opposite side of the pool which resulted in a 180°rotation of the test conditions (altered platform test). Escape latencies were measured in s with a 60 s cut-off time over 5 daily test sessions with a 5 min inter-trial interval.
Open-field acti6ity
The novelty-induced activities of all experimental groups were measured, initially described by Gray and Lalljee [15] , in an open-field test box. This consisted of a circular arena 80 cm in diameter, which was divided into 20 sectors by faint brown lines and surrounded by a 60 cm high aluminum wall. Illumination was provided by a 30 W bulb positioned 60 cm above the floor of the apparatus. All measurements were carried out in a darkened and quiet room. The test was started by placing the rat in the center of the arena. Each test lasted for 3 min, during which (i) the degree of horizontal ambulation (the number of line-crossings), (ii) the number of times and (iii) the total time the rat spent in an upright position (rearing) and (iv) the number of fecal boli deposited (defecations) were recorded. In fact, iAP(Phe(SO 3 H) 24 )25-35 treatment did not influence the number of fecal boli deposited in the open-field (data not shown).
Tissue processing and histochemistry
Fixation of the brains was carried out under deep chloral hydrate anesthesia (500 mg/kg body weight) by transcardial perfusion with 300 ml fixative composed of 4% para-formaldehyde and 0.05% glutardialdehyde in 0.1 M phosphate buffer (PB, pH 7.4) at a perfusion speed of 15 ml/min. This was preceded by a short prerinse of heparinized saline. After removing the brains from the skull they were cryoprotected by overnight storage at 4°C in 30% sucrose in 0.1 M PB. Subsequently, the brains were coronally sectioned on a cryostat microtome at a thickness of 20 vm. Sections of iAP(Phe(SO 3 H) 24 )25-35-injected and sham-operated animals were processed simultaneously. Before sectioning, the brains of sham-operated rats were marked by punching a small needle hole in the corpus callosum. The free floating brain sections were post-fixed by immersion in a 2.5% glutardialdehyde solution in phosphate buffered saline overnight at 4°C. The cholinergic fibers were then visualized by staining for AChE (EC 3.1.1.7) according to Hedreen et al. [20] using a silver nitrate intensification procedure. Finally, the sections were mounted, dehydrated, coverslipped and examined by light microscopy.
To determine the effect of iAP(Phe(SO 3 H) 24 
Statistical analysis
Results on altered animal behavior, expressed as medians, were statistically evaluated with the non-parametric Kruskal-Wallis or Mann -Whitney U-tests. Changes in body weight (means9S.D.) were analyzed using paired Student's t-test. The degree of cortical fiber reduction (means 9S.E.M.) was calculated by the one-way analysis of variance (ANOVA) test. P B 0.05 was taken as indicative of statistical significance for the tests. This was calculated with a computer program for an IBM PC (MINITAB ® , Release 9.2, 1993, Minitab, Staten College, PA).
Results
Beha6ioral changes
The measurement of motor behavior of rats in their home cage revealed a biphasic activity response as a result of iAP(Phe(SO 3 H) 24 )25 -35 infusions ( Fig. 2a,b ). Fig. 2a ). This was followed by a transient period of decreased mobility of the iAP group between 2 and 5 days post-surgery. On post-lesion day 6 an overt, permanent hyperactivity was determined for the iAP-injected group (Fig. 5 ). The rapid development of this activity increase was noted. The median ambulation scores of iAP(Phe(SO 3 H) 24 )25-35treated rats on days 4 and 5 post-operation differed significantly (776 vs. 1366, total daily activity values; PB 0.01, Fig. 2a ). Furthermore, daily analysis of the home cage activity values for both the iAP-lesioned and sham-controls during the hyperactive period indicated significant alterations that mainly occurred dur-ing the dark phase (from 20.00 to 08.00 h; P B0.01, P B 0.05, Fig. 2b ). iAP(Phe(SO 3 H) 24 )25 -35 injections did not influence behavioral activities in the early light phase. Thus, this did not affect the circadian rhythm of the animals (Fig. 2c ), although significant differences were also observed in the last 3 h of the light period (PB0.01, Fig. 2b) .
iAP-lesioned rats showed a significant reduction in novelty-induced locomotion 1, 4, 7, 10 and 14 days after iAP(Phe(SO 3 H) 24 Fig. 3a) . Although the rats were tested four times in the locomotor activity task no adaptation to the test conditions was observed. Baseline observations (3 days prior to surgery) of the animals tested under home cage circumstances did not reveal differences in the locomotor activity of the experimental groups (data not shown). Compared to the sham-operated and naive control groups (P B 0.01), the arousal of iAP-injected rats was greatly reduced in the initial phase of the 15 min test periods as shown in Fig. 3b , while sham-operated animals habituated normally to the test conditions.
We have previously demonstrated [6, 18, 19 ] that iAP (1 -42) exerts marked neurotoxic effects and induces cholinergic cell death after a 14-day survival period. Thus, in these experiments, alterations of retention mechanisms and acquisition were investigated 2 weeks post-surgery in the step-through passive avoidance and 'Morris' water maze paradigms (Fig. 4a,b ). When tested for passive avoidance before re-entering the shock-compartment, iAP injected bilaterally in the nbm significantly decreased the post-shock latencies 24 h after the delivery of a mild foot-shock, compared to both sham-operated and control animals (59 [lesioned] vs. 180 [sham or naive controls] s; P B 0.05 or P B 0.01, respectively, Fig. 4a ). This indicates the short-term impairment of 'cortical' retention mechanisms. The performance of naive and vehicle-injected rats did not differ from each other in the test. In accordance with the perturbed locomotor functions, preshock latencies of iAP(Phe(SO 3 H) 24 )25 -35-lesioned rats were mildly increased (data not shown).
Behavioral effects of iAP(Phe(SO 3 H) 24 )25 -35 lesions on spatial orientation were investigated in the 'Morris' water maze task. The performance in this test was expressed as the escape latency from the water maze to the submerged, invisible platform in both the fixed (trial 1-15) and altered (trial 16 -25) positions. Fig. 4b shows that the acquisition, defined as the decreased escape latency over repeated trials, revealed no obvious differences between the iAP-injected and sham-operated control groups. It was noted, that the rats progressively learned the test across days, so long-term retention appeared unaffected. Moreover, greatly increased escape latencies of iAP-lesioned rats were recorded in the sixth training session (first trial on day 2). Fig. 6a ). Conversely, another group of iAP-injected rats, initially trained in the step-through passive avoidance task, exhibited a marked hyperactivity in the novel environment of the open-field arena (P=0.083, Fig. 6b ). These iAP-lesioned animals were more active but showed no improvement in exploration.
AChE-positi6e profiles in the paffetal cortex
Thirty five days after bilateral injections of iAP(Phe(SO 3 H) 24 )25-35 in the nbm, AChE histochemistry was used to visualize aberrations of cholinergic fibres in parietal cortical sections. In this paper, we confined our analysis to pathological changes of the cortical cholinergic innervation, since alterations in the intimate interactions of cholinergic nbm structures and neocortical regions have been previously demonstrated to direct behavioral and learning/memory functions [3, 27, 28, 35, 36, 45, 46] . As a result of iAP-(Phe(SO 3 H) 24 )25-35 injections, cholinergic projection neurons of the nbm exhibited characteristic signs of neurodegeneration (e.g. their fibres showed a beaded appearance; data not shown). This is similar to those described in our earlier studies after intracerebral iAP (1 -42) application [18] . Degenerating projection fibers scattered through the cortical area investigated resembled the loss of projection neurites following ei-ther iAP (25 -35) or iAP (1 -42) infusion in the nbm [6, 19] . iAP(Phe(SO 3 H) 24 )25-35 treatment elicited the loss of AChE-positive fibres in all layers of the parietal cortex. This was most apparent in superficial layers, for example in the areas of layer 4 and 5 of the cerebral cortical (Fig. 7a ). Quantitative analysis of the density of AChEpositive projection fibers in the posterior somatosensory cortex revealed a 18.459 4.31% loss of cholinergic neurons 35 days after iAP(Phe(SO 3 H) 24 )25 -35 infusions, relative to the sham-operated animals (P B0.05). It was noted that AChE-positive processes invading the parietal cortex showed decreased staining intensities as a consequence of iAP(Phe(SO 3 H) 24 )25 -35 infusion into the nbm (Fig. 7a ). This might also reflect malfunctioning of the cortical cholinergic system. No differences were found between the AChE-positive cortical staining patterns of sham-operated and naive control animals. 
Discussion
The family of iAP is a heterogeneous group of proteins, which might be generated in successive cleavage processes of different APP isoforms or from the mature iAP (1 -42) fragment itself [8, 17] . The abundant appearance of several iAP fragments in AD tissues [2, 41] indicates that the actual molecular milieu influences these cleavage mechanisms; e.g. an acidic compartment or unbalanced metabolic supply-induced acidosis might enhance these mechanisms [6] . A lot of recent papers demonstrated that iAP fragments differ both in their chemical [2, 38] and physiological properties [6, 12, 24, 25, 38] and elicit neurodegeneration [7, 18, 19] , although the particular molecular events of this neurotoxic pathway are still to be ascertained. However, the state of peptide assembly has been proposed as an essential factor in the neurotoxic mechanisms [39] . Furthermore, Giovannelli et al. [12] reported different toxicity profiles for iAP (25 -35) and iAP (1 -40) , which were recently corroborated by De Jong et al. [6] . In conclusion, the three dimensional peptide structure and the aggregation and water-solubility of iAP might determine the peptides' effects. To resolve the possible role of these chemical characteristics a modified peptide, namely the iAP(Phe(SO 3 H) 24 )25 -35 fragment, initiated by coupling of the large but chemically inert Phe(SO 3 H) group to the biologically active iAP (25 -35) sequence, was used in these studies. This modification resulted in a water-soluble peptide fragment which is protected against exoprotease cleavage and has a relatively low metabolic turnover, but bears the biological activity of iAP (25 -35) (Penke et al. , unpublished observations). On the basis of the persistent behavioral and histochemical abnormalities observed we assume that aggregation and/or fibril formation is not a prerequisite for iAP neurotoxicity. iAP fragments released extracellularly may elicit neurotoxic cascades via acting on specific cell surface targets (receptors) or by their virtue to form free radicals [31] , while peptide aggregation may exacerbate these mechanisms. Indeed, small iAP fragments without a discrete tertiary structure undergo rapid enzymatic degradation as suggested previously [12] .
Loss of cholinergic projection neurons in the basal forebrain, particularly those of the nbm, may play a central role in the cognitive decline associated with aging and AD [3] . In this regard, lesions to the nbm induced by injections of excitotoxins [11, 35, 46] have been frequently used to induce cholinergic malfunctioning. Recent papers using either intracerebral iAP infusions [9, 12, 36] or transgenic animals [10, 33] revealed marked deficits in learning skills and memory functions accompanied by extensive iAP deposition [6, 36] and even AD-like neuropathology [10] . In these experiments alterations in spontaneous animal behavior and memory functions were investigated. Extensive changes in home cage behavior as a result of bilateral iAP(Phe(SO 3 H) 24 )25-35 injections became evident as early as 24 h after peptide infusions. They showed a biphasic profile and were maintained throughout the survival period. iAP treatment of hippocampal neurons was established to elicit a rapid and persistent elevation in [Ca 2 + ] i . This was accompanied by a remarkable elevation of firing, potentiation of excitatory post-synaptic potentials and large increases in postsynaptic Ca 2 + levels in vitro [29, 31, 38] . The early, brief hyperactive peak in iAP(Phe(SO 3 H) 24 )25-35-lesioned rats' home cage activities might be attributed, therefore, to an increased Ca 2 + influx in the projection neurons of the nbm. The rise in [Ca 2 + ] i may result in hyperexcitability and an increased transmitter release [14] eliciting the hyperactivity that was observed. Furthermore, the transient hypoactivity, and the persistent overt mobility response occurring exclusively during the dark periods, may correlate with iAP-induced degeneration of nbm (cholinergic) projection neurons and the subse-quent loss of the regulation of higher cortical functions. Similarly, transgenic mice expressing the 751-amino acid isoform of the human APP (APP 751 ) exhibited lower activity responses than wild type mice which became apparent exclusively during the dark periods [33] .
Locomotor activity has been suggested as a possible behavioral screen for neuronal damage following brain injury [32] . In parallel with the increase in general activity, iAP(Phe(SO 3 H) 24 )25 -35-lesioned rats exhibited a significant reduction in novelty-induced explorative behavior in the locomotor arena. In accordance with previously reported changes in locomotion after ischemia [4] , activity changes might reflect the degree of neuronal damage. The neurotoxic action of iAP(Phe(SO 3 H) 24 )25-35 induced a significant hypoactivity which was of greatest magnitude during the first 5-min block of each test-period. Habituation of shamoperated and naive control rats to the test conditions masked these responses in later phases of the experiments. Studies using iAP (1 -42) fragments revealed similar reductions in locomotion in a small open-field task 14 days after surgery (De Jong and Harkany, unpublished data).
Magnocellular regions of the basal forebrain are recognized as critical sites of sleep-wake and arousal regulation [42] . Furthermore, recent research suggests that this cholinergic system plays an important role in attentional processes, as was determined in an associative learning framework after 192 IgG-saporin-induced immunotoxic lesions [5] . Cholinergic nbm neurons have recently been established to mediate neocortical and limbic arousal-associated and cognitive functions within the waking state [42] . While non-cholinergic, presumably GABAergic cells in the substantia innominata, maintaining intimate interactions with the cholinergic magnocellular nerve cells, are responsible for sleep-promoting nbm functions. Since GABAergic interneurons are relatively preserved after iAP infusions [18] they maintain the normal circadian rhythm of the animals. Conversely, cholinergic malfunctioning in the nbm may result in significantly higher mobility values and persistent hyperactivity during the dark periods. This is due to the increased activity of the cholinergic magnocellular projection neurons. The disturbances in sensory information processing (arousal regulation) may account for the loss of cholinergic nerve cells in the nbm, and that of the neocortical innervation because of iAP-induced excitotoxic damage, which results in decreased locomotor activities.
Several in vivo investigations demonstrated that iAP directly influence learning and memory functions. In fact, both acute injections into the basal ganglia or limbic structures [9, 12] and prolonged peptide infusion [36] affect these mechanisms. In these experiments iAP(Phe(SO 3 H) 24 )25-35 injections in the nbm induced marked impairment of cortical retention mechanisms, as was defined in the passive avoidance paradigm. It was noted that preshock latencies of iAP(Phe(SO 3 H) 24 )25-35-lesioned rats increased (data not shown) thus indicating a persistent decrease in explorative rearing. This was accompanied by a dramatic decrease in the latencies before re-entering the shock-compartment in the retention trial. In addition, escape latencies in the 'Morris' water maze showed unaltered long-term acquisition or retention in the test. Combining the data suggests a severe derangement of cortical memory functions which results in the decline of short-term memory and reflects specific, site-directed effects of the peptide. These results concur with the findings of Flood et al. [9] showing that iAP exert direct neurotoxic properties on nbm structures resulting in the impairment of 'cortical' learning and memory functions. However, recent studies using iAP (25 -35) or iAP (1 -40) have failed to show memory disturbances when tested for passive avoidance conditioned responses, although a shortening of the retest latency was found [12] . In fact, the tertiary structure and relatively low levels of peptide breakdown may play a pivotal role in the long-lasting neurotoxic actions.
Previous studies [18, 19] demonstrate that iAP (1 -42) elicits cholinergic malfunctioning 14 days after intracerebral injections. Since only transient effects of iAP (25 -35) have been reported [12] , an attempt was made in this investigation to determine long-lasting changes after iAP(Phe(SO 3 H) 24 )25-35 injections. In this respect, persistently increased home cage activities and altered open-field behavior indicated long-lasting disruption of neural functions. iAP(Phe(SO 3 H) 24 )25-35-lesioned rats previously trained in the step-through passive avoidance test showed a marked hyperactivity in a novel environment, although without an improvement in exploration. The difference between iAP(Phe(SO 3 H) 24 )25-35-treated and sham-operated or naive control groups may indicate a persistent amnesic effect of peptide infusions, since the illuminated arena did not elicit a conditioned fear response in rats injected with iAP(Phe(SO 3 H) 24 )25-35. By contrast, ambulation scores of sham-operated and naive control animals were relatively suppressed, presumably as the long-lasting effect of the passive avoidance task. Open-field responses of rats initially trained in the light-independent 'Morris' water maze paradigm revealed persistent decreases in exploration, manifested as the loss in explorative rearing. These data concur with our findings in the locomotor activity task 1, 4, 7, 10 and 14 days post-surgery, reflecting the persistent, long-lasting depression of locomotion.
Extensive damages to the cortical AChE-positive fibre aberrations provided an anatomical substrate for the behavioral changes elicited by iAP-(Phe(SO 3 H) 24 )25-35 injections. In accordance with our previous observations [18] cholinergic projection neurons of the nbm appeared to be severely damaged by iAP(Phe(SO 3 H) 24 )25-35 infusions and underwent neurodegeneration (data not shown) 35 days post-injection. Pronounced morphological aberrations [6, 7, 18, 19] and biochemical disturbances [1, 19] after intracortical or intrahippocampal iAP injections, provide evidence for the direct cholinotoxic effects of the peptide fragments. Emre et al. [7] reported the most significant loss of cortical cholinergic innervation approximately 14 days post-injection. These observations have recently been corroborated by De Jong et al. [6] who found the most severe AChE-positive fibre loss 3 days after surgery which was maintained up to 21 days post-operation. In this investigation the analysis of AChE fibre distribution in all layers of the parietal cortex revealed extensive loss of cortical cholinergic innervation following iAP(Phe(SO 3 H) 24 )25-35 injections and the behavioral changes correlated with the extent of cholinergic cell death (data not shown). We assume, therefore, that the modified iAP(Phe(SO 3 H) 24 )25 -35 peptide preserves the neurotoxic potential of iAP (25 -35) and exerts direct cholinotoxic properties.
In summary, microinjections of the non-aggregating, water-soluble iAP(Phe(SO 3 H) 24 )25 -35 peptide elicit profound changes in spontaneous animal behavior and disrupt learning and memory functions. This stable tertiary structure with the Phe(SO 3 H) group protecting against exoprotease cleavage may contribute to the persistent changes in animal behavior and the loss of AChE-positive structures in the rat somatosensory cortex. The different vulnerability of sleep-wake and attentional processes regulated by GABAergic or cholinergic mechanisms might display, even if indirectly, predominantly cholinotoxic properties of iAP. These data might indicate that potentially amyloidogenic iAP fragments, when released extracellularly, induce neurodegeneration prior to fibril or plaque formation. Furthermore, disturbances in yet unidentified protease activities in the brain directing the intra-and/or extracellular enzymatic degradation of iAP may trigger the accumulation and deposition of iAP initiating exacerbation of the neurodegenerative cascade. This new family of modified iAP allows the modelling of specific effects of truncated iAP fragments in long-term experiments and in the present model the effectiveness of neuroprotective drug therapies can be studied directly.
